Profound Medical Corp. Files 6-K with December Press Release

Ticker: PROF · Form: 6-K · Filed: Dec 11, 2024 · CIK: 1628808

Profound Medical Corp. 6-K Filing Summary
FieldDetail
CompanyProfound Medical Corp. (PROF)
Form Type6-K
Filed DateDec 11, 2024
Risk Levellow
Pages1
Reading Time1 min
Sentimentneutral

Sentiment: neutral

Topics: sec-filing, 6-K, press-release

TL;DR

Profound Medical Corp. (PRN) filed a 6-K on Dec 11, including a Dec 10 press release. Check for updates.

AI Summary

Profound Medical Corp. filed a Form 6-K on December 11, 2024, reporting a press release dated December 10, 2024. The company is incorporated in Ontario and its fiscal year ends on December 31. This filing is made under the 1934 Securities Exchange Act.

Why It Matters

This filing indicates that Profound Medical Corp. is providing updated information to the SEC, likely related to recent business developments or announcements made in their December 10th press release.

Risk Assessment

Risk Level: low — A Form 6-K is a routine filing for foreign private issuers to report material information, and this specific filing does not indicate any immediate or significant risks.

Key Players & Entities

  • Profound Medical Corp. (company) — Filer of the 6-K
  • December 10, 2024 (date) — Date of the press release
  • December 11, 2024 (date) — Filing date of the 6-K
  • 2400 Skymark Avenue, Unit 6, Mississauga, Ontario L4W 5K5 (address) — Principal executive office address

FAQ

What is the primary purpose of this Form 6-K filing?

The primary purpose of this Form 6-K filing is to report a press release dated December 10, 2024, as required by the Securities Exchange Act of 1934 for foreign private issuers.

What is the filing date of this Form 6-K?

This Form 6-K was filed on December 11, 2024.

What is the name of the company filing this report?

The company filing this report is Profound Medical Corp.

What is the address of Profound Medical Corp.'s principal executive office?

The address of Profound Medical Corp.'s principal executive office is 2400 Skymark Avenue, Unit 6, Mississauga, Ontario L4W 5K5.

Which exhibit is incorporated by reference in this filing?

Exhibit 99.1, a press release dated December 10, 2024, is incorporated by reference in this filing.

Filing Stats: 165 words · 1 min read · ~1 pages · Grade level 12.9 · Accepted 2024-12-10 17:35:19

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. PROFOUND MEDICAL CORP. (Registrant) Date: December 10, 2024 /s/ Rashed Dewan Rashed Dewan Chief Financial Officer

View Full Filing

View this 6-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.